CHARGE syndrome: genes and variants
Explore variant evidence for CHARGE syndrome across 1 analyzed protein (CHD7). Linked ClinVar records include 42 pathogenic or likely pathogenic variants, 775 variants of uncertain significance and 339 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to CHARGE syndrome
CHD7: ATP-dependent chromatin remodeler CHD7
It regulates chromatin accessibility and developmental gene programs across multiple embryonic tissues. Haploinsufficiency is the major cause of CHARGE syndrome, which can affect the eyes, heart, choanae, growth, genital development, ears, and nervous system.
42 ClinVar pathogenic / likely pathogenic and 1,114 uncertain variants in CHD7 have source records linked to CHARGE syndrome. Association strength is not clinical gene validity.
Where CHARGE syndrome variants cluster
- CHD7 Helicase C-terminal (positions 1294–1464): 7 of 42 ClinVar pathogenic / likely pathogenic variants, 2.9× more than its size predicts (a length-based count, not a validated hotspot).
- CHD7 Helicase ATP-binding (positions 980–1154): 7 of 42 ClinVar pathogenic / likely pathogenic variants, 2.9× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to CHARGE syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CHD7 R1345H | 1345 | Helicase C-terminal | Pathogenic / likely pathogenic (★★) |
| CHD7 H2096R | 2096 | Pathogenic / likely pathogenic (★★) | |
| CHD7 K1076E | 1076 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| CHD7 C1101R | 1101 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| CHD7 V1208D | 1208 | Pathogenic / likely pathogenic (★★) | |
| CHD7 L1294P | 1294 | Helicase C-terminal | Pathogenic / likely pathogenic (★★) |
| CHD7 T1416R | 1416 | Helicase C-terminal | Pathogenic / likely pathogenic (★★) |
| CHD7 G1684S | 1684 | Pathogenic / likely pathogenic (★★) | |
| CHD7 G2108R | 2108 | Pathogenic / likely pathogenic (★★) | |
| CHD7 F2124S | 2124 | Pathogenic / likely pathogenic (★★) | |
| CHD7 N1030S | 1030 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| CHD7 R1399G | 1399 | Helicase C-terminal | Pathogenic / likely pathogenic (★) |
| CHD7 Q1214H | 1214 | Pathogenic / likely pathogenic (★) | |
| CHD7 Q1214P | 1214 | Pathogenic / likely pathogenic (★) | |
| CHD7 R1743C | 1743 | Pathogenic / likely pathogenic (★) | |
| CHD7 G1802S | 1802 | Pathogenic / likely pathogenic (★) | |
| CHD7 R1915Q | 1915 | Pathogenic / likely pathogenic (★) | |
| CHD7 Q746H | 746 | Pathogenic / likely pathogenic (★) | |
| CHD7 L997S | 997 | Helicase ATP-binding | Pathogenic / likely pathogenic (★) |
| CHD7 W1031C | 1031 | Helicase ATP-binding | Pathogenic / likely pathogenic (★) |
| CHD7 W1099R | 1099 | Helicase ATP-binding | Pathogenic / likely pathogenic (★) |
| CHD7 L1126F | 1126 | Helicase ATP-binding | Pathogenic / likely pathogenic (★) |
| CHD7 C1251R | 1251 | Pathogenic / likely pathogenic (★) | |
| CHD7 L1302P | 1302 | Helicase C-terminal | Pathogenic / likely pathogenic (★) |
| CHD7 S1313P | 1313 | Helicase C-terminal | Pathogenic / likely pathogenic (★) |
| CHD7 R1557G | 1557 | Pathogenic / likely pathogenic (★) | |
| CHD7 C1643Y | 1643 | Pathogenic / likely pathogenic (★) | |
| CHD7 D1812E | 1812 | Pathogenic / likely pathogenic (★) | |
| CHD7 F1817C | 1817 | Pathogenic / likely pathogenic (★) | |
| CHD7 G1982W | 1982 | Pathogenic / likely pathogenic (★) | |
| CHD7 D2097H | 2097 | Pathogenic / likely pathogenic (★) | |
| CHD7 E871D | 871 | Pathogenic / likely pathogenic (★) | |
| CHD7 G1845E | 1845 | Pathogenic / likely pathogenic (★) | |
| CHD7 E2012V | 2012 | Pathogenic / likely pathogenic (★) | |
| CHD7 D1596V | 1596 | Pathogenic / likely pathogenic (★) | |
| CHD7 N2588S | 2588 | Pathogenic / likely pathogenic (★) | |
| CHD7 R2319S | 2319 | Pathogenic / likely pathogenic | |
| CHD7 S834F | 834 | Chromo 1 | Pathogenic / likely pathogenic |
| CHD7 Q972R | 972 | Pathogenic / likely pathogenic | |
| CHD7 L1257R | 1257 | Pathogenic / likely pathogenic | |
| CHD7 S1406R | 1406 | Helicase C-terminal | Pathogenic / likely pathogenic |
| CHD7 I2688R | 2688 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in CHARGE syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CHD7 R1345C | 1345 | Helicase C-terminal | Conflicting reports (★) | +7: R1345H at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.934 |
| CHD7 N1030T | 1030 | Helicase ATP-binding | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; N1030S at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.914 |
Which prediction tools work for CHARGE syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- EVE: 96 out of 100
- REVEL: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 93 out of 100
- ESM1b (LLR): 93 out of 100
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 71 out of 100
- phyloP: 67 out of 100
- SpliceAI: 67 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 27 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- CHD7-related CHARGE syndrome also has ClinVar records linked to CHD7 variants; they fall partly in the same places as the CHARGE syndrome variants (8 pathogenic / likely pathogenic).
- Hypogonadotropic hypogonadism 5 with or without anosmia also has ClinVar records linked to CHD7 variants; they fall partly in the same places as the CHARGE syndrome variants (7 pathogenic / likely pathogenic).
Diseases related to CHARGE syndrome
- Wiedemann-Steiner syndrome, also linked to CHD7
- CHD7-related CHARGE syndrome, also linked to CHD7
- Joubert syndrome, also linked to CHD7
- Hypogonadotropic hypogonadism 5 with or without anosmia, also linked to CHD7
- Hypogonadotropic hypogonadism, also linked to CHD7
Frequently asked questions
Which genes have records linked to CHARGE syndrome?
This view contains 1 analyzed proteins: CHD7. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 42 pathogenic or likely pathogenic variants, 775 variants of uncertain significance and 339 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,495 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center